55.13
price down icon2.42%   -1.37
after-market Handel nachbörslich: 56.19 1.06 +1.92%
loading

Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten

pulisher
07:44 AM

Supernus a new buy at BofA on 'underappreciated' CNS assets - MSN

07:44 AM
pulisher
06:21 AM

Supernus Pharmaceuticals Inc. stock trendline breakdownWeekly Stock Report & Momentum Based Trading Ideas - newser.com

06:21 AM
pulisher
05:22 AM

Advanced analytics toolkit walkthrough for Supernus Pharmaceuticals Inc.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com

05:22 AM
pulisher
05:01 AM

Can Supernus Pharmaceuticals Inc. stock continue upward trendDollar Strength & Fast Entry High Yield Stock Tips - newser.com

05:01 AM
pulisher
04:10 AM

Top chart patterns to watch in Supernus Pharmaceuticals Inc.2025 Market Trends & High Accuracy Buy Signal Tips - newser.com

04:10 AM
pulisher
12:53 PM

How to monitor Supernus Pharmaceuticals Inc. with trend dashboardsEarnings Risk Report & Safe Swing Trade Setup Alerts - newser.com

12:53 PM
pulisher
12:16 PM

Why Supernus Pharmaceuticals Inc. stock remains undervaluedBond Market & AI Forecasted Entry and Exit Points - newser.com

12:16 PM
pulisher
12:02 PM

Sentiment analysis tools applied to Supernus Pharmaceuticals Inc.Market Growth Summary & Fast Gain Swing Trade Alerts - newser.com

12:02 PM
pulisher
Oct 30, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $55.95 - Markets Mojo

Oct 30, 2025
pulisher
Oct 30, 2025

Long term hold vs stop loss in Supernus Pharmaceuticals Inc.IPO Watch & Risk Controlled Swing Alerts - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

What institutional flow reveals about Supernus Pharmaceuticals Inc.Treasury Yields & Community Verified Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals Inc Stock Analysis and ForecastQuarterly Earnings Review & Rapid Portfolio Appreciation - earlytimes.in

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Gains Market Attention with Key CNS Drugs - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to Buy - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

Can Supernus Pharmaceuticals Sustain Momentum After 13% Jump on Neuroscience Pipeline News? - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals Hits New 52-Week High of $53.28 - Markets Mojo

Oct 29, 2025
pulisher
Oct 29, 2025

BofA Securities Initiates Supernus Pharmaceuticals at Buy With $65 Price Target - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

B of A Securities Initiates Coverage on SUPN with a Buy Rating | - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Supernus Pharmaceuticals (SUPN) Price Target Increased by 32.88% to 59.36 - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

B of A Securities Initiates Coverage of Supernus Pharmaceuticals (SUPN) with Buy Recommendation - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

Is Supernus Pharmaceuticals Inc. stock near bottom after decline2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Using data models to predict Supernus Pharmaceuticals Inc. stock movementTrade Analysis Summary & Safe Entry Trade Reports - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

It’s Clear How Big Money Flows Lift Supernus - Yahoo Finance

Oct 29, 2025
pulisher
Oct 28, 2025

Will Supernus Pharmaceuticals Inc. stock gain from lower inflationJuly 2025 Selloffs & Safe Entry Point Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Earnings Preview: Supernus Pharmaceuticals (SUPN) Q3 Earnings Expected to Decline - sharewise.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Supernus Pharmaceuticals Inc. stock supported by strong fundamentalsWeekly Investment Summary & Smart Swing Trading Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Is Supernus Pharmaceuticals Inc. stock attractive after correctionEntry Point & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - sharewise.com

Oct 27, 2025
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Kapitalisierung:     |  Volumen (24h):